• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Therapeutic potential of LDL apheresis including activation of receptor-interacting molecule in the management of peripheral artery disease

Research Project

  • PDF
Project/Area Number 24890189
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Circulatory organs internal medicine
Research InstitutionYokohama City University

Principal Investigator

IKEYA Yuko  横浜市立大学, 附属病院, 指導診療医 (60453049)

Project Period (FY) 2012-08-31 – 2014-03-31
Keywordsシグナル伝達 / 脂質 / 循環器・高血圧 / 生体分子 / トランスレーショナルリサーチ
Research Abstract

Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney disease (CKD). Patients with CKD are reported to have a significant greater risk of CVD-associated mortality than that of the general population. Low-density lipoprotein (LDL) apheresis is a potentially valuable treatment applied to conventional therapy-resistant hypercholesterolemic patients with coronary artery disease and peripheral artery disease (PAD). Although previous and recent studies have suggested that LDL apheresis exerts beneficial effects on the peripheral circulation in dialysis patients suf- fering from PAD, probably through a reduction of not only serum lipids but also of inflammatory or coagulatory factors and oxidative stress, the precise molecular mechanisms underlying the long-term effects of LDL apheresis on the improvement of the peripheral circulation remains unclear and warrants further investigation, including a possible role of Ang II receptor-interacting molecule, ATRAP.

  • Research Products

    (11 results)

All 2013 2012 Other

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Remarks (1 results)

  • [Journal Article] Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein2013

    • Author(s)
      Matsuda M, Tamura K, Wakui H, Maeda A, Ohsawa M, Kanaoka T, Azushima K, Uneda K, Haku S, Tsurumi-Ikeya Y, Toya Y, Maeshima Y, Yamashita A, Umemura S
    • Journal Title

      J Biol Chem

      Volume: 288 Pages: 19238-19249

    • DOI

      10.1074/jbc.M113.451054

    • Peer Reviewed
  • [Journal Article] What can we expect from the binding characteristics of azilsartan, a newly available angiotensin II blocker, in hypertension?2013

    • Author(s)
      Tamura K, Ohsawa M, Kanaoka T, Maeda A, Azushima K, Uneda K, Wakui H, Azuma K, Tsurumi-Ikeya Y, Umemura S
    • Journal Title

      Hypertens Res

      Volume: 36 Pages: 107-108

    • DOI

      10.1038/hr.2012.166

    • Peer Reviewed
  • [Journal Article] Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease2013

    • Author(s)
      Tamura K, Tsurumi-Ikeya Y, Wakui H, Maeda A, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Haku S, Azuma K, Mitsuhashi H, Tamura N, Toya Y, Tokita Y, Kokuho T, Umemura S
    • Journal Title

      Ther Apher Dial

      Volume: 17 Pages: 185-192

    • DOI

      10.1111/j.1744-9987.2012.01149.x

    • Peer Reviewed
  • [Journal Article] Enhanced Ang receptor-associated protein in renal tubule suppresses Ang-dependent hypertension2013

    • Author(s)
      Wakui H, Tamura K, Masuda S, Tsurumi-Ikeya Y, Fujita M, Maeda A, Ohsawa M, Azushima K, Uneda K, Matsuda M, Kitamura K, Uchida S, Toya Y, Kobori H, Nagahama K, Yamashita A, Umemura S
    • Journal Title

      Hypertension

      Volume: 61 Pages: 1203-1210

    • DOI

      10.1161/HYPERTENSIONAHA.111.00572

    • Peer Reviewed
  • [Journal Article] The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap2013

    • Author(s)
      Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A, Umemura S
    • Journal Title

      Curr Pharm Des

      Volume: 19 Pages: 3043-3048

    • DOI

      10.2174/1381612811319170010

    • Peer Reviewed
  • [Journal Article] Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease2013

    • Author(s)
      Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S
    • Journal Title

      Int J Mol Sci

      Volume: 14 Pages: 15361-15375

    • DOI

      10.3390/ijms140815361

    • Peer Reviewed
  • [Journal Article] Umemura S.L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease2013

    • Author(s)
      Kanaoka T, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Fujikawa T, Tsurumi-Ikeya Y, Maeda A, Yanagi M, Toya Y
    • Journal Title

      Int J Mol Sci

      Volume: 14 Pages: 16866-16881

    • DOI

      10.3390/ijms140816866

    • Peer Reviewed
  • [Journal Article] An increase in perfusion pressure and activation of the renin-angiotensin system in the pathogenesis of hypertension and injury : strain vessels and the cerebrovascular-renal connection2012

    • Author(s)
      Tamura K, Maeda A, Uneda K, Wakui H, Dejima T, Mitsuhashi H, Yamaguchi S, Tsurumi-Ikeya Y, Tokita Y, Umemura S
    • Journal Title

      Hypertens Res

      Volume: 35 Pages: 972-974

    • DOI

      10.1038/hr.2012.108

    • Peer Reviewed
  • [Journal Article] Genetic deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension

    • Author(s)
      Ohsawa M, Tamura K, Wakui H, Maeda A, Dejima T, Kanaoka T, Azushima K, Uneda K, Tsurumi-Ikeya Y, Kobayashi R, Matsuda M, Uchida S, Toya Y, Kobori H, Nishiyama A, Yamashita A, Ishikawa Y, Umemura S
    • Journal Title

      Kidney Int

      Volume: (in press)

    • DOI

      10.1038/ki.2014.95

    • Peer Reviewed
  • [Journal Article] Effects of the angiotensin receptor blocker olmesartan on adipocyte hypertrophy and function in mice with metabolic disorders

    • Author(s)
      Maeda A, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kanaoka T, Kobayashi R, Ohki K, Matsuda M, Tsurumi-Ikeya Y, Yamashita A, Tokita Y, Umemura S
    • Journal Title

      BioMed Res Int

      Volume: (in press)

    • DOI

      10.1155/2014/946492

    • Peer Reviewed
  • [Remarks]

    • URL

      http://www.yokohama-medicine.org

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi